Tessellate BIO

📍 Amsterdam, Netherlands👥 27 employees💰 Last funded Oct 2021
Biotechnology Research🌐 tessellatebio.com
Website LinkedIn
Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in Tessellate BIO?
Tessellate BIO has 1 investors on record on gritt.io.
When did Tessellate BIO last raise funding?
The most recent investment in Tessellate BIO recorded on gritt.io was in October 2021.
What industry is Tessellate BIO in?
Tessellate BIO operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tessellate BIO based?
Tessellate BIO is headquartered in Amsterdam, Netherlands.